Tidelands Health administers 10,000th dose of COVID-19 vaccine
Tidelands Health reached a milestone in COVID-19 vaccine distribution Thursday when clinicians administered their 10,000th dose of the lifesaving vaccine.
Since administering its first dose Dec. 16 to an ICU nurse, the health system has aggressively rolled out the vaccine to eligible individuals over the past six weeks, including not only Tidelands Health team members but also more than 1,300 mission-critical community workers, nearly 6,000 seniors 70 and older and others in Phase 1a of the SC DHEC vaccine distribution guidelines.
“This is a moment to celebrate,” said Gayle Resetar, chief operating officer of Tidelands Health. “In just six weeks, our team has rallied to roll out this highly anticipated vaccine safely, quickly and efficiently. We know this is the path to putting the pandemic behind us, and we are working to administer vaccine as quickly as supply allows.”
Even with 10,000 doses administered, the rollout of the COVID-19 vaccine is just beginning. Nearly 30,000 Phase 1a individuals remain on the list to receive their first and second doses of the vaccine from Tidelands Health. And the health system continues to administer second doses to several thousand individuals who have already received their initial shot.
Tens of thousands of individuals in later phases of the state guidelines are also eagerly awaiting their opportunity to receive the vaccine.
Tidelands Health has established designated community vaccine clinics in Georgetown and Murrells Inlet and is hiring up to 200 temporary workers to support those clinics. The National Guard is also supporting the vaccination effort.
The health system will continue to vaccinate those in the community following the timeline and phases set by the state. Those eligible to receive the COVID-19 vaccine in Phase 1a can request a vaccine at tidelandshealth.org. Not sure if you are in Phase 1a? Click here to review the guidelines at scdhec.gov.
While administering the vaccine, Tidelands Health also continues to care for surging numbers of hospitalized COVID-19 patients and administer a promising outpatient treatment -- monoclonal antibody therapy -- to help prevent hospitalization among high-risk COVID-19-positive patients.
“Our team has been battling this deadly virus on all fronts,” Resetar said. “The vaccine provides us hope, and no one is more motivated to get it into people’s arms than our community’s health care workers.”